APH
NEUTRALAlliance Pharma Announces Major Shareholder Disclosure
The healthcare company has received a notification of a major shareholder holding, with Glazer Capital, LLC now owning over 7.9% of the shares.
APH
0.00%
Market Cap
Volume
0
NaN% of avg
P/E Ratio
N/A
EPS (TTM)
N/A
Beta
N/A
Day Range
p - p
52 Week Range
N/AppN/Ap
p
No data available for this timeframe
APH
NEUTRALAlliance Pharma Announces Director Dealings
The healthcare company has announced changes to its major shareholders.
APH
NEUTRALAlliance Pharma Announces Director Dealings
The healthcare company has announced changes to its major shareholders.
APH
NEUTRALAlliance Pharma Director to Acquire Shares Ahead of Scheme
The director of the healthcare company plans to purchase additional shares before the proposed acquisition scheme is completed.
APH
GOODAlliance Pharma Publishes Annual Report
The healthcare company has published its annual report, providing investors with an update on the business's performance and operations over the past year.
APH
BADAlliance Pharma Reports Mixed Results Amid Challenging Market Conditions
The healthcare group faced headwinds, reporting a statutory loss and flat underlying profits. Despite improved cash flow and reduced debt, declining revenues in key brands and challenging market conditions paint a mixed picture.
APH
NEUTRALAlliance Pharma Satisfies Regulatory Conditions for Acquisition
The healthcare company has satisfied regulatory conditions for its acquisition, moving the deal closer to completion.
APH
NEUTRALAlliance Pharma Announces Change in Major Shareholding
The healthcare company has announced a change in its major shareholding, with Sand Grove Capital Management LLP reducing its stake.
APH
GOODAlliance Pharma Receives Final Increased Recommended Cash Offer
The drug manufacturer receives a final increased recommended cash offer to be acquired, with the board endorsing the terms as fair and reasonable.
APH
NEUTRALAlliance Pharma Announces Change in Major Shareholding
The healthcare company has notified a change in major shareholding, with an investor increasing its stake.